Stone Four Medicine Group (02005.HK): Lincomycin Hydrochloride Injection (2ml:0.6g) passes the evaluation of consistency in quality and efficacy of generic drugs.

Zhito Finance APP News, Sisai Pharmaceutical Group (02005.HK) announced that the group's Lincomycin Hydrochloride Injection (2ml:0.6g) has obtained approval from the China National Medical Products Administration for generic drug quality and efficacy consistency evaluation.